Skip to main content
. 2009 May 20;2(3):141–147. doi: 10.4021/gr2009.05.1289

Table 5. Actuarial overall survival (n = 48).

Category Number of Patients (%)
Number remaining alive 9 (18.8%)
Death of intrahepatic disease 16 (33.3%)
Death of extrahepatic disease 7 (14.6%)
Death of complications of further Treatment 10 (20.8%)
Death of unrelated cause 6 (12.5%)
Actuarial survival
   1 year 75%
   2 year 45.8%
   3 year 27.1%
Median survival time 15.5 months (95%CI,12.7-27)